News

Filter News By

Clear Filters

  1. CF Foundation Awards Contract to Life Edit Therapeutics to Explore Gene Editing Technology in CF

    March 23, 2021

    Today, the Cystic Fibrosis Foundation announced that it has awarded up to $400,000 to Life Edit Therapeutics Inc. to explore the application of their unique gene editing technology in CF.

  2. CF Foundation Awards Up to $2.17 Million to Beyond Air® to Develop Portable NTM Treatment

    February 16, 2021

    Today, the Cystic Fibrosis Foundation announced that it has awarded up to $2.17 million to Beyond Air® to support the development of a portable inhaled nitric oxide treatment for nontuberculous mycobacteria, difficult-to-treat bacteria that infect the lungs of people with cystic fibrosis.

  3. CF Foundation Has Awarded Up to $3M to Kinnear Pharmaceuticals for Anti-Infective

    January 26, 2021

    The Cystic Fibrosis Foundation has awarded up to $3 million to Kinnear Pharmaceuticals to conduct preclinical testing of a broad-spectrum anti-infective that has the potential to treat multi-drug resistant Pseudomonas and other infections in people with cystic fibrosis.

  4. Cystic Fibrosis Foundation Announces Nine Research Agreements to Advance Its Path to a Cure

    December 10, 2020

    The Cystic Fibrosis Foundation announced a new set of research agreements to drive progress on its Path to a Cure. The nine awards will advance a variety of tools and strategies to accelerate treatments for the underlying cause of cystic fibrosis for all people with CF, regardless of their mutations.

  5. CF Foundation Awards $2.76 Million for 11 COVID-19 Studies

    December 9, 2020

    Today, the Cystic Fibrosis Foundation awarded $2.76 million for 11 laboratory studies that will advance our understanding of the underlying factors that impact COVID-19 outcomes in people with cystic fibrosis. Ultimately, insights gained from this body of research may be used to improve future treatments.

  6. First Global Study of COVID-19 in Children With Cystic Fibrosis Reports Reassuring Outcomes

    December 9, 2020

    The Cystic Fibrosis Registry Global Harmonization Group, including the Cystic Fibrosis Foundation, published findings from the first global study on the impact of COVID-19 on children with cystic fibrosis in the Journal of Cystic Fibrosis.
More Posts View All Posts

Related Content

Follow Us On